Carlsmed Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $56.4M+58.2% YoYTTM through 31 Mar 2026
Net Income -$32.6MTTM through 31 Mar 2026
Free Cash Flow -$34.5MTTM through 31 Mar 2026
Margins
| Current | |
|---|---|
| Gross Margin | 77.1% |
| Operating Margin | -60.5% |
| Net Margin | -54.0% |
Returns
-35.3%ROE
-27.5%ROA
Balance Sheet Health
Debt / Equity0.17x
Current Ratio11.88x
Net Debt-$81.5Mnet cash position
Cash & Equivalents$73M
Quality Metrics
FCF Margin-61.2%
Rule of 40-28.5
Earnings-Beat Rate75.0%
Dividend
No dividend
Segment Performance
No segment data available.
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.